Together with our previous ROCK-ezrin signaling regulates the intrahepatic cancer metastasis, we identified a novel chemical drug, celastrol, which could target the ROCK2-ezrin signaling as a potential therapeutic drug to prevent the hepatocellular carcinoma metastasis. Here, EZR is linked to hepatocellular carcinoma.